Adagio Medical Holdings, Inc. (ADGM): who owns it and who trades it
As of Nov 16, 2026, ADGM insiders reported 2 purchases worth $244K in the last 12 months. The largest buyer was Todd Usen (CEO), with $226K. 2 of the 50 famous funds we follow held it at their last quarter end.
Latest filing Nov 16, 2026. From Form 4, 13F and Schedule 13D/G filings.
At a glance
Who is buying and selling Adagio Medical Holdings
From the latest filingsOverall: more buying than selling. Insiders and famous investors mostly bought.
Each group counts equally in the meter, by the number of buyers and sellers, not dollars. Insider sales under pre-set 10b5-1 plans are left out of it. From SEC, House and Senate filings; not advice.
Insider trades
In the last 12 months, ADGM insiders reported $244K of open-market purchases and $0 of sales.
Purchases and sales by month
Latest trades
| Date | Insider | Role | Type | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| Dec 16, 2025 | Deborah Kaster | CFO | Purchase | 15,000 | $1.20 | $18K | Form 4 |
| Dec 12, 2025 | Todd Usen | CEO | Purchase | 207,315 | $1.09 | $226K | Form 4 |
Insiders by value traded
| Insider | Role | Bought | Sold | Last trade |
|---|---|---|---|---|
| Todd Usen | Chief Executive Officer, Director | $226K | – | Dec 12, 2025 |
| Deborah Kaster | Chief Financial Officer | $18K | – | Dec 16, 2025 |
What this data shows, and what it doesn't
- Shows: open-market purchases and sales by officers, directors and 10%+ owners, reported on Form 4 within two business days of the trade.
- Leaves out: stock awards, option exercises, shares withheld for tax and gifts. These are not trades at a market price chosen by the insider.
- "plan" marks a sale made under a Rule 10b5-1 plan, a schedule set up in advance.
- Fund holders come from 13F reports, a snapshot at quarter end filed up to 45 days later.
- Filings are self-reported and can be amended. Each trade links to its original filing. Methodology
ADGM short interest
Low short interest. 0.7% of ADGM shares are sold short: about 1 share in 143. Over the last 12 reports the number of shares short went up 280%.
As a rough guide, under 5% is low, 5–10% is moderate, 10–20% is high and over 20% is very high.
As of Oct 30, 2026, 155,672 ADGM shares were sold short, 0.7% of the shares outstanding, up 17.1% from the report before. At the average daily volume of 872,346 shares, buying them all back would take about 1.0 trading days (days to cover).
Shares short, % of all shares
Days to cover
Every report
| Settlement date | Shares short | % of shares | Change | Avg daily volume | Days to cover |
|---|---|---|---|---|---|
| Oct 30, 2026 | 155,672 | 0.70% | +17% | 872,346 | 1.0 |
| Oct 15, 2026 | 132,959 | 0.60% | -90% | 4.09M | 1.0 |
| Sep 30, 2026 | 1.29M | 5.80% | +212% | 4.54M | 1.0 |
| Sep 15, 2026 | 412,796 | 1.86% | +59% | 182,972 | 2.3 |
| Aug 31, 2026 | 259,188 | 1.17% | -20% | 335,517 | 1.0 |
| Aug 14, 2026 | 325,415 | 1.47% | +446% | 50.42M | 1.0 |
| Jul 31, 2026 | 59,553 | 0.27% | -5% | 89,058 | 1.0 |
| Jul 15, 2026 | 62,497 | 0.28% | +4% | 65,240 | 1.0 |
| Jun 30, 2026 | 60,242 | 0.27% | -14% | 63,500 | 1.0 |
| Jun 15, 2026 | 69,890 | 0.31% | +9% | 97,381 | 1.0 |
| May 29, 2026 | 63,955 | 0.29% | +56% | 184,914 | 1.0 |
| May 15, 2026 | 40,990 | 0.18% | -35% | 52,997 | 1.0 |
Short sellers borrow shares and sell them, hoping to buy them back for less. A high number means many such bets are open. It does not say where the price will go. Source: FINRA equity short interest, reported by brokers twice a month (positions on the 15th and the last business day) and published about 7 business days later. % of shares uses the share count on the company's latest SEC filing. What short interest means · Most shorted stocks
Adagio Medical Holdings company events
Adagio Medical Holdings filed 17 reports on Form 8-K in the last 12 months, 3 of them about an important change (leadership, listing). The latest was on Nov 5, 2026.
- Nov 5, 2026RulesChanged its bylaws or articles. Filing
- Oct 26, 2026VoteReported shareholder vote results. Filing
- Oct 1, 2026SharesSold new shares outside a public offering. Filing
- Sep 23, 2026AnnouncementIn connection with its process to explore strategic alternatives, the Company notified holders of its 13% Senior Secured Convertible Notes, that it would lower the Conversion Price (as defined in the Notes) of the Notes for each date during the period commencing on September 23, 2026 and ending on… Filing
- Aug 14, 2026ListingAdagio Medical Holdings, Inc. received a deficiency letter from the Listing Qualifications Department of the Nasdaq Stock Market notifying the Company that it is not in compliance with the minimum stockholders’ equity requirement for continued listing on the Nasdaq Capital Market. Filing
- Aug 13, 2026AnnouncementShared information with investors. Filing
- Aug 11, 2026ResultsReleased financial results. Filing
- Jun 16, 2026VoteReported shareholder vote results. Filing
- Jun 12, 2026ListingAdagio Medical Holdings, Inc. received a notice from the Listing Qualifications Department of The Nasdaq Stock Market LLC notifying the Company that the listing of its common stock was not in compliance with Nasdaq Listing Rule 5550(a)(2) for continued listing on The Nasdaq Capital Market, as the… Filing
- May 21, 2026AnnouncementAdagio Medical Holdings, Inc. issued a press release entitled “Adagio Medical Submits Premarket Approval Application to FDA for vCLAS® Ventricular Ablation System for the Treatment of Ventricular Tachycardia.” The full text of the press release is attached hereto as Exhibit 99.1 to this Current… Filing
- May 12, 2026ResultsReleased financial results. Filing
- Apr 27, 2026AnnouncementAdagio Medical Holdings, Inc. issued a press release entitled “Adagio Medical Announces Positive Pivotal Results for vCLAS® Ventricular Ablation System.” The full text of the press release is attached hereto as Exhibit 99.1 to this Current Report on Form 8-K and incorporated herein by reference. Filing
- Apr 20, 2026VoteSet dates for shareholder nominations. Filing
- Apr 8, 2026AnnouncementAdagio Medical Holdings, Inc. issued a press release entitled “Adagio Medical Receives IDE Approval from the FDA to Investigate the Next-Generation vCLAS™ Ventricular Ablation System.” The full text of the press release is attached hereto as Exhibit 99.1 to this Current Report on Form 8-K and… Filing
- Mar 27, 2026ResultsReleased financial results. Filing
- Dec 16, 2025VoteReported shareholder vote results. Filing
- Dec 11, 2025LeadershipThe Board of Directors of Adagio Medical Holdings, Inc. increased the size of the Board from six to seven directors and appointed Sean Salmon as a Class II director of the Company, with his term expiring at the Company’s 2026 annual meeting of stockholders. Filing
From 8-K reports, which a company must file within 4 business days of an important event. Where a report is about a change such as a new CEO, the sentence is the first one from the report itself, shortened. Each row links to the original filing. Company events this week
Adagio Medical Holdings financials
Famous investors that hold ADGM
2 of the 50 well-known investors we track reported holding ADGM in their latest 13F filing. The largest position is Ken Griffin's, worth $11.7K.
| Fund | Quarter | Shares | Value | Of portfolio | Change |
|---|---|---|---|---|---|
| Ken Griffin · Citadel Advisors | Q3 2026 | 76,212 | $11.7K | 0.0% | +372% |
| Steve Cohen · Point72 Asset Management | Q3 2026 | 20,143 | $3.1K | 0.0% | New |
From 13F reports: a snapshot at quarter end, filed up to 45 days later. Change compares with the quarter before.
5%+ stakes filed in the last 120 days
Anyone who owns more than 5% of a company must report it on Schedule 13D or 13G. 2 filings named ADGM in the last 120 days.
| Filed | Holder | Form | Stake |
|---|---|---|---|
| Nov 16, 2026 | Perceptive Advisors LLC | 13G/A | 44.4% |
| Nov 16, 2026 | Perceptive Advisors LLC | 13G/A | 44.4% |
Questions about Adagio Medical Holdings, Inc. (ADGM) stock
Are ADGM insiders buying or selling?
In the last 12 months, ADGM insiders reported 2 open-market purchases worth $244K and no sales. The latest trade was on Dec 16, 2025. See every trade.
What is the short interest in ADGM?
As of Oct 30, 2026, 155,672 ADGM shares were sold short, 0.7% of the shares outstanding, up 17.1% from the report before. At the average daily volume of 872,346 shares, buying them all back would take about 1.0 trading days (days to cover). See the history.
Which famous investors hold ADGM?
2 of the 50 well-known investors we track reported ADGM in their latest 13F filing, including Ken Griffin, Steve Cohen. The largest position is worth $11.7K. See all holders.
Source: SEC Form 4 (insiders, filed within 2 business days), 13F (funds, up to 45 days after quarter end) and Schedule 13D/13G filings. Only open-market purchases (code P) and sales (code S) are shown. Data only, not investment advice. How we collect it.